SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 58 filers reported holding SESEN BIO INC in Q4 2020. The put-call ratio across all filers is 12.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $199,984 | +41.8% | 328,111 | -1.3% | 0.00% | – |
Q3 2022 | $141,000 | -47.6% | 332,423 | 0.0% | 0.00% | – |
Q2 2022 | $269,000 | -74.3% | 332,423 | -80.9% | 0.00% | – |
Q1 2022 | $1,048,000 | -28.5% | 1,736,790 | -3.4% | 0.00% | – |
Q4 2021 | $1,465,000 | +2.9% | 1,797,262 | +0.1% | 0.00% | – |
Q3 2021 | $1,424,000 | -81.7% | 1,795,924 | +6.4% | 0.00% | -100.0% |
Q2 2021 | $7,794,000 | +900.5% | 1,687,142 | +463.4% | 0.00% | – |
Q1 2021 | $779,000 | +145.7% | 299,453 | +27.4% | 0.00% | – |
Q4 2020 | $317,000 | -4.5% | 235,003 | -1.0% | 0.00% | – |
Q3 2020 | $332,000 | +107.5% | 237,357 | +6.6% | 0.00% | – |
Q2 2020 | $160,000 | +28.0% | 222,722 | 0.0% | 0.00% | – |
Q1 2020 | $125,000 | -27.7% | 222,722 | +34.1% | 0.00% | – |
Q4 2019 | $173,000 | -13.1% | 166,047 | -2.4% | 0.00% | – |
Q3 2019 | $199,000 | +2.1% | 170,048 | +30.4% | 0.00% | – |
Q2 2019 | $195,000 | +46.6% | 130,371 | +0.7% | 0.00% | – |
Q1 2019 | $133,000 | -42.4% | 129,406 | -20.4% | 0.00% | – |
Q4 2018 | $231,000 | -34.0% | 162,612 | -0.3% | 0.00% | – |
Q3 2018 | $350,000 | +11.1% | 163,096 | +1.1% | 0.00% | – |
Q2 2018 | $315,000 | – | 161,254 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |